Top healthcare mergers and acquisitions in September 2026
Every verified merger and acquisition in the healthcare sector in this period, ranked by disclosed value. Updated every morning.
We tracked 3 deals in the healthcare sector in September 2026, 2 of them with a disclosed value, worth $13.7bn in total. The largest was Merck KGaA's $11.3bn deal for Bio-Techne, ahead of Telix Pharmaceuticals and ITM Isotope Technologies Munich at $2.4bn.
Top healthcare mergers and acquisitions in September 2026
- 123 SeptMerck KGaA → Bio-TechneBio-Techne shareholders back $11.3bn sale to Merck KGaAHealthcare / Life-science toolsIn review$11.3bn
- 220 SeptTelix Pharmaceuticals → ITM Isotope Technologies MunichTelix agrees up to $2.35bn deal for Munich's ITMHealthcare / RadiopharmaAgreed$2.4bn
- 317 SeptEB Development → Eurobio ScientificEurobio Scientific's owner moves to delist at €25.30 a shareHealthcareAnnouncedUndisclosed